Pages that link to "Q67218920"

The following pages link to Genetics of Parkinson's disease (Q67218920):

Displaying 43 items.

• Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions (Q22009563) (← links)
• Gene therapy in Parkinson's disease: rationale and current status (Q22241423) (← links)
• Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy (Q24683089) (← links)
• Data-mining analysis suggests an epigenetic pathogenesis for type 2 diabetes (Q24811670) (← links)
• Drug elucidation: invertebrate genetics sheds new light on the molecular targets of CNS drugs (Q27693888) (← links)
• Shattuck lecture--neurodegenerative diseases and prions (Q28189500) (← links)
• Id2 is required for specification of dopaminergic neurons during adult olfactory neurogenesis (Q28593714) (← links)
• Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system (Q28594866) (← links)
• Argument-predicate distance as a filter for enhancing precision in extracting predications on the genetic etiology of disease (Q33246173) (← links)
• The WD40 domain is required for LRRK2 neurotoxicity (Q33521241) (← links)
• Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein. (Q33594388) (← links)
• Uncoupling the Trade-Off between Somatic Proteostasis and Reproduction in Caenorhabditis elegans Models of Polyglutamine Diseases (Q33615396) (← links)
• Understanding the biological activity of amyloid proteins in vitro: from inhibited cellular MTT reduction to altered cellular cholesterol homeostatis (Q33666823) (← links)
• Alpha-synuclein disrupted dopamine homeostasis leads to dopaminergic neuron degeneration in Caenorhabditis elegans (Q33670439) (← links)
• Modulation of Amyloid β-Protein (Aβ) Assembly by Homologous C-Terminal Fragments as a Strategy for Inhibiting Aβ Toxicity. (Q33745468) (← links)
• Identification of 167 polymorphisms in 88 genes from candidate neurodegeneration pathways (Q33881161) (← links)
• The emergence of modern neuroscience: some implications for neurology and psychiatry (Q33904974) (← links)
• A novel "molecular tweezer" inhibitor of α-synuclein neurotoxicity in vitro and in vivo. (Q34030874) (← links)
• Role of alpha-synuclein protein levels in mitochondrial morphology and cell survival in cell lines (Q34257471) (← links)
• The Hunt for a Cure for Parkinson’s Disease (Q35577679) (← links)
• Neurodegenerative disorders associated with diabetes mellitus (Q35791191) (← links)
• Protein Homeostasis in Models of Aging and Age-Related Conformational Disease (Q36109387) (← links)
• Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta (Q36156158) (← links)
• Nanotools for megaproblems: probing protein misfolding diseases using nanomedicine modus operandi (Q36615206) (← links)
• Autophagy and neurodegeneration: when the cleaning crew goes on strike (Q36760662) (← links)
• Loss of leucine-rich repeat kinase 2 (LRRK2) in rats leads to progressive abnormal phenotypes in peripheral organs (Q37308940) (← links)
• MicroRNA implications across neurodevelopment and neuropathology (Q37617954) (← links)
• Alpha-synuclein and intracellular trafficking: impact on the spreading of Parkinson's disease pathology. (Q38101508) (← links)
• Tristetraprolin inhibits mitochondrial function through suppression of α-Synuclein expression in cancer cells (Q38836746) (← links)
• Transcriptome Profile Changes in Mice with MPTP-Induced Early Stages of Parkinson's Disease (Q39273083) (← links)
• Progress toward an integrated understanding of Parkinson's disease (Q41012014) (← links)
• Inheritance of frontotemporal dementia (Q41679025) (← links)
• Drug Targeting of alpha-Synuclein Oligomerization in Synucleinopathies (Q41865629) (← links)
• Merging mouse transcriptome analyses with Parkinson's disease linkage studies (Q41902132) (← links)
• A central role for TOR signalling in a yeast model for juvenile CLN3 disease (Q41907776) (← links)
• Differential strain susceptibility following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration acts in an autosomal dominant fashion: quantitative analysis in seven strains of Mus musculus. (Q42471915) (← links)
• The human sideroflexin 5 (SFXN5) gene: sequence, expression analysis and exclusion as a candidate for PARK3. (Q44011529) (← links)
• Neurodegeneration and glutamate induced oxidative stress. (Q48291492) (← links)
• Variable PARK2 Mutations Cause Early-Onset Parkinson's Disease in a Small Restricted Population (Q48341795) (← links)
• Identification of a single QTL, Mptp1, for susceptibility to MPTP-induced substantia nigra pars compacta neuron loss in mice (Q48385648) (← links)
• Dementia with Lewy bodies: an update and outlook (Q61446034) (← links)
• The role of posttranslational modifications of α-synuclein and LRRK2 in Parkinson's disease: Potential contributions of environmental factors (Q64811522) (← links)
• The Challenge to Search for New Nervous System Disease Biomarker Candidates: the Opportunity to Use the Proteogenomics Approach (Q90564396) (← links)